minoxidil has been researched along with Myxedema in 1 studies
Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.
Myxedema: A condition characterized by a dry, waxy type of swelling (EDEMA) with abnormal deposits of MUCOPOLYSACCHARIDES in the SKIN and other tissues. It is caused by a deficiency of THYROID HORMONES. The skin becomes puffy around the eyes and on the cheeks. The face is dull and expressionless with thickened nose and lips.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Priestley, GC | 1 |
| Aldridge, RD | 1 |
| Sime, PJ | 1 |
| Wilson, D | 1 |
1 other study available for minoxidil and Myxedema
| Article | Year |
|---|---|
Skin fibroblast activity in pretibial myxoedema and the effect of octreotide (Sandostatin) in vitro.
Topics: Adult; Cell Division; Cells, Cultured; Female; Fibroblasts; Glycosaminoglycans; Humans; Leg Dermatos | 1994 |